{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:49:06Z","timestamp":1794901746943,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Correct inhaler use depends on a complex interplay of factors, including device preparation and generating sufficient inspiratory flow. It is currently unknown which inhalation technique errors can be considered critical in Chronic Obstructive Pulmonary Disease (COPD) patients on Dry Powder Inhaler (DPI) maintenance therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the association between inhalation technique errors and health status or exacerbations in patients with COPD. Additionally, the association between the number of errors and COPD outcomes was determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The PIFotal study is a cross-sectional multi-country observational study in a primary care setting, including 1434 COPD patients aged\u2009\u2265\u200940\u00a0years (50.1% female; mean age 69.2 yrs) using a DPI for their maintenance therapy. Inhalation technique was video recorded and scored by two independent researchers using inhaler-specific checklists. Health status was assessed with two questionnaires; the Clinical COPD Questionnaire (CCQ) and the COPD Assessment Test (CAT). The number of moderate and severe exacerbations in the past 12\u00a0months was recorded. Critical errors were identified based on their association with health status or exacerbations through multi-level prediction models adjusted for identified confounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Errors in inhalation technique steps \u2018Breathe in\u2019, \u2018Hold breath\u2019, and \u2018Breathe out calmly after inhalation\u2019 were significantly associated with poorer CCQ and CAT outcomes and thus deemed critical. None of the errors were significantly associated with moderate exacerbations. Patients with errors \u2018Preparation\u2019, \u2018Hold inhaler in correct position during inhalation\u2019, and \u2018Breathe in\u2019 had significantly more severe exacerbations, and therefore these errors were also deemed critical. 81.3% of patients with COPD made at least one critical error. Specific combinations of errors were associated with worse outcomes. The more inhalation technique errors identified, the poorer the health status and the higher the exacerbation rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, we identified multiple critical inhalation technique errors in COPD patients using DPIs each associated with poorer outcomes. Explorative analysis revealed that specific combinations of errors may be of clinical relevance, especially those related to the inhalation manoeuvre. COPD outcomes worsened with increasing error count. These results warrant further prospective longitudinal studies to establish the effect of correcting these errors on COPD control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04532853\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04532853<\/jats:ext-link>\n                      (31\/08\/2020)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02566-6","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T07:02:41Z","timestamp":1692255761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study"],"prefix":"10.1186","volume":"23","author":[{"given":"Janwillem","family":"Kocks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinthia","family":"Bosnic-Anticevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"van Cooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Correia de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Cvetkovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dekhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Garcia Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asparuh","family":"Gardev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rados\u0142aw","family":"Gawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"van der Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ymke","family":"Janse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Lavorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Maricoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiska","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyd","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Roman Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Schuttel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilouq","family":"Stoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Tsiligianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaco","family":"Voorham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika T.","family":"Leving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"2566_CR1","unstructured":"2023 GOLD Report - Global Initiative for Chronic Obstructive Lung Disease - GOLD. Cited 2022 Nov 29. Available from: https:\/\/goldcopd.org\/2023-gold-report-2\/"},{"issue":"2","key":"2566_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1183\/09031936.06.00025805","volume":"27","author":"AD Lopez","year":"2006","unstructured":"Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397\u2013412.","journal-title":"Eur Respir J"},{"issue":"10","key":"2566_CR3","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1007\/s12325-019-01066-6","volume":"36","author":"ML Levy","year":"2019","unstructured":"Levy ML, Carroll W, Izquierdo Alonso JL, Keller C, Lavorini F, Lehtim\u00e4ki L. Understanding dry powder inhalers: key technical and patient preference attributes. Adv Ther. 2019;36(10):2547\u201357.","journal-title":"Adv Ther"},{"issue":"4","key":"2566_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.rmed.2007.11.003","volume":"102","author":"F Lavorini","year":"2008","unstructured":"Lavorini F, Magnan A, Christophe Dubus J, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593\u2013604.","journal-title":"Respir Med"},{"issue":"2","key":"2566_CR5","doi-asserted-by":"publisher","first-page":"1601794","DOI":"10.1183\/13993003.01794-2016","volume":"49","author":"M Molimard","year":"2017","unstructured":"Molimard M, Raherison C, Lignot S, Balestra A, Lamarque S, Chartier A, et al. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017;49(2):1601794 Cited 2021 Dec 15. Available from: https:\/\/erj.ersjournals.com\/content\/49\/2\/1601794.","journal-title":"Eur Respir J."},{"issue":"1","key":"2566_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-017-0710-y","volume":"19","author":"OS Usmani","year":"2018","unstructured":"Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, et al. Critical inhaler errors in asthma and COPD: A systematic review of impact on health outcomes. Respir Res. 2018;19(1):1\u201320 Cited 2021 Dec 14. Available from: https:\/\/link.springer.com\/articles\/10.1186\/s12931-017-0710-y.","journal-title":"Respir Res."},{"issue":"1","key":"2566_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41533-018-0110-x","volume":"28","author":"JWH Kocks","year":"2018","unstructured":"Kocks JWH, Chrystyn H, van der Palen J, Thomas M, Yates L, Landis SH, et al. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD. NPJ Prim Care Respir Med. 2018;28(1):1\u20136 Cited 2021 Dec 15. Available from: https:\/\/www.nature.com\/articles\/s41533-018-0110-x .","journal-title":"NPJ Prim Care Respir Med."},{"key":"2566_CR8","doi-asserted-by":"crossref","unstructured":"Kocks JWH, Wouters H, Bosnic-Anticevich S, van Cooten J, Correia de Sousa J, Cvetkovski B, et al. Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers. NPJ Prim Care Respir Med. 2022;32(1\u201318).","DOI":"10.1038\/s41533-022-00282-y"},{"issue":"23","key":"2566_CR9","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.3390\/jcm10235683","volume":"10","author":"R Pech\u00e9","year":"2021","unstructured":"Pech\u00e9 R, Attar-zadeh D, Scullion J, Kocks J. Matching the Inhaler to the Patient in COPD. J Clin Med. 2021;10(23):5683 Cited 2022 Feb 4. Available from: https:\/\/www.mdpi.com\/2077-0383\/10\/23\/5683\/htm .","journal-title":"J Clin Med."},{"issue":"2","key":"2566_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/biomedicines10020458","volume":"10","author":"MT Leving","year":"2022","unstructured":"Leving MT, Kocks J, Bosnic-Anticevich S, Dekhuijzen R, Usmani OS. Relationship between Peak Inspiratory Flow and Patient and Disease Characteristics in Individuals with COPD: a systematic scoping review. Biomedicines. 2022;10(2):458 Cited 2022 Feb 21. Available from: https:\/\/www.mdpi.com\/2227-9059\/10\/2\/458\/htm .","journal-title":"Biomedicines."},{"issue":"1","key":"2566_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41533-022-00318-3","volume":"32","author":"MT Leving","year":"2022","unstructured":"Leving MT, Bosnic-Anticevich S, van Cooten J, de Sousa JC, Cvetkovski B, Dekhuijzen R, et al. Clinical recommendations for dry powder inhaler use in the management of COPD in primary care. NPJ Primary Care Respir Med. 2022;32(1):1\u20138 Cited 2023 May 8. Available from: https:\/\/www.nature.com\/articles\/s41533-022-00318-3 .","journal-title":"NPJ Primary Care Respir Med."},{"issue":"4","key":"2566_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.amjmed.2008.09.042","volume":"122","author":"RG Barr","year":"2009","unstructured":"Barr RG, Celli BR, Mannino DM, Petty T, Rennard SI, Sciurba FC, et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med. 2009;122(4):348\u201355.","journal-title":"Am J Med"},{"issue":"4","key":"2566_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jaip.2017.01.004","volume":"5","author":"DB Price","year":"2017","unstructured":"Price DB, Rom\u00e1n-Rodr\u00edguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, et al. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract. 2017;5(4):1071\u20131081.e9.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2566_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41533-017-0016-z","volume":"27","author":"H Chrystyn","year":"2017","unstructured":"Chrystyn H, van der Palen J, Sharma R, Barnes N, Delafont B, Mahajan A, et al. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med. 2017;27(1):1\u201310 Cited 2021 Dec 15. Available from: https:\/\/www.nature.com\/articles\/s41533-017-0016-z.","journal-title":"NPJ Prim Care Respir Med."},{"issue":"6","key":"2566_CR15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.rmed.2011.01.005","volume":"105","author":"AS Melani","year":"2011","unstructured":"Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930\u20138.","journal-title":"Respir Med"},{"key":"2566_CR16","doi-asserted-by":"crossref","unstructured":"Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of Handling of Inhaler Devices in Real Life: An Observational Study in 3811 Patients in Primary Care. 2004;16(3):249\u201354. Cited 2021 Dec 15.\u00a0http:\/\/www.liebertpub.com\/jam.\u00a0Available from: https:\/\/www.liebertpub.com\/doi\/abs\/10.1089\/089426803769017613.","DOI":"10.1089\/089426803769017613"},{"issue":"2","key":"2566_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4104\/pcrj.2012.00010","volume":"21","author":"W Azouz","year":"2012","unstructured":"Azouz W, Chrystyn H. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J. 2012;21(2):208 Cited 2022 Jan 11. Available from: \/pmc\/articles\/PMC6547917\/.","journal-title":"Prim Care Respir J."},{"issue":"9","key":"2566_CR18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3109\/02770903.2015.1025408","volume":"52","author":"T Kondo","year":"2015","unstructured":"Kondo T, Hibino M, Tanigaki T, Ohe M, Kato S. Exhalation immediately before inhalation optimizes dry powder inhaler use. J Asthma. 2015;52(9):935\u20139 Cited 2022 Jan 11. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26513654\/ .","journal-title":"J Asthma."},{"issue":"2","key":"2566_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s41030-021-00172-7","volume":"7","author":"M Leving","year":"2021","unstructured":"Leving M, Wouters H, de la Hoz A, Bosnic-Anticevich S, Dekhuijzen R, Gardev A, et al. Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study). Pulm Ther. 2021;7(2):591\u2013606 Cited 2021 Dec 14. Available from: https:\/\/link.springer.com\/article\/10.1007\/s41030-021-00172-7 .","journal-title":"Pulm Ther."},{"issue":"1","key":"2566_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-7-26","volume":"7","author":"B St\u00e4llberg","year":"2009","unstructured":"St\u00e4llberg B, Nokela M, Ehrs PO, Hjemdal P, Jonsson EW. Validation of the Clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes. 2009;7(1):1\u20139 Cited 2021 Dec 15. Available from: https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-7-26 .","journal-title":"Health Qual Life Outcomes."},{"issue":"3","key":"2566_CR21","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648\u201354 Cited 2021 Dec 15. Available from: https:\/\/erj.ersjournals.com\/content\/34\/3\/648 .","journal-title":"Eur Respir J."},{"key":"2566_CR22","volume-title":"REVIEW: Evolution of dry powder inhaler design, formulation, and performance","author":"SP Newman","year":"2002","unstructured":"Newman SP, Busse WW. REVIEW: Evolution of dry powder inhaler design, formulation, and performance. 2002."},{"key":"2566_CR23","doi-asserted-by":"publisher","unstructured":"Clark AR, Hollingworth AM. The Relationship Between Powder Inhaler Resistance and Peak Inspiratory Conditions in Healthy Volunteers \u2014 Implications for In Vitro Testing. http:\/\/www.liebertpub.com\/jam. 2009;6(2):99\u2013110. Cited 2021 Dec 17. Available from: https:\/\/www.liebertpub.com\/doi\/abs\/, https:\/\/doi.org\/10.1089\/jam.1993.6.99.","DOI":"10.1089\/jam.1993.6.99"},{"issue":"2","key":"2566_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/thx.32.2.194","volume":"32","author":"D Pavia","year":"1977","unstructured":"Pavia D, Thomson ML, Clarke SW, Shannon HS. Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax. 1977;32(2):194\u20137 Cited 2022 Jan 11. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/867333\/ .","journal-title":"Thorax."},{"issue":"6","key":"2566_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/thx.48.6.607","volume":"48","author":"M Hindle","year":"1993","unstructured":"Hindle M, Newton DAG, Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. Thorax. 1993;48(6):607\u201310 Cited 2022 Jan 11. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/8346489\/.","journal-title":"Thorax."},{"issue":"6","key":"2566_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1590\/S1806-37132011000600004","volume":"37","author":"A Carla","year":"2011","unstructured":"Carla A, Coelho C, Souza-Machado A, Leite M, Almeida P, Castro L, et al. Use of inhaler devices and asthma control in severe asthma patients at a referral center in the city of Salvador, Brazil* Manuseio de dispositivos inalat\u00f3rios e controle da asma em asm\u00e1ticos graves em um centro de refer\u00eancia em Salvador*. J Bras Pneumol. 2011;37(6):720\u20138.","journal-title":"J Bras Pneumol"},{"key":"2566_CR27","doi-asserted-by":"publisher","unstructured":"Westerik JAM, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, et al. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.\u00a02016;53(3):321\u20139.\u00a0https:\/\/doi.org\/10.3109\/02770903.2015.1099160. Cited 2021 Dec 15. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.3109\/02770903.2015.1099160.","DOI":"10.3109\/02770903.2015.1099160"},{"issue":"2","key":"2566_CR28","doi-asserted-by":"publisher","first-page":"10S","DOI":"10.1378\/chest.117.2_suppl.10S","volume":"117","author":"PJ Barnes","year":"2000","unstructured":"Barnes PJ. Mechanisms in COPD: differences from asthma. Chest. 2000;117(2):10S\u201314S.","journal-title":"Chest"},{"key":"2566_CR29","unstructured":"Inhalation MagazineThe effects of inhaler type and orientation at inhalation on dosing.... Cited 2023 Jun 21. Available from: https:\/\/www.inhalationmag.com\/article\/the-effects-of-inhaler-type-and-orientation-at-inhalation-on-dosing-efficiency-a-study-of-the-smi-pmdi-and-dpi\/"},{"key":"2566_CR30","doi-asserted-by":"publisher","unstructured":"Buttini F, Quarta E, Allegrini C, Lavorini F. Understanding the Importance of Capsules in Dry Powder Inhalers. Pharmaceutics. 2021; Available from: https:\/\/doi.org\/10.3390\/pharmaceutics13111936","DOI":"10.3390\/pharmaceutics13111936"},{"key":"2566_CR31","doi-asserted-by":"publisher","unstructured":"Ding L, Brunaugh AD, Stegemann S, Jermain S v, Herpin MJ, Kalafat J, et al. A Quality by Design Framework for Capsule-Based Dry Powder Inhalers. Pharmaceutics. 2021; Available from: https:\/\/doi.org\/10.3390\/pharmaceutics13081213","DOI":"10.3390\/pharmaceutics13081213"},{"issue":"104","key":"2566_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejps.2017.03.047","volume":"15","author":"A Horv\u00e1th","year":"2017","unstructured":"Horv\u00e1th A, Bal\u00e1sh\u00e1zy I, Tomisa G, Farkas \u00c1. Significance of breath-hold time in dry powder aerosol drug therapy of COPD patients. Eur J Pharm Sci. 2017;15(104):145\u20139.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"2566_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-021-02000-w","volume":"19","author":"MA Alsallakh","year":"2021","unstructured":"Alsallakh MA, Sivakumaran S, Kennedy S, Vasileiou E, Lyons RA, Robertson C, et al. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales. BMC Med. 2021;19(1):1\u201310 Cited 2021 Dec 15. Available from: https:\/\/link.springer.com\/articles\/10.1186\/s12916-021-02000-w .","journal-title":"BMC Med."}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02566-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02566-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02566-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T12:06:34Z","timestamp":1700309194000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02566-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2566"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02566-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The PIFotal COPD study protocol has received approvals from the following institutional ethics committees\/institutional review boards: Australia: Human Research Ethics Committee (HREC 3) University of Sydney; Greece: Research Ethics Committee University of Crete; Poland: Komisja Bioetyczna przy Beskidziej Izble Lekarskiej \u2013 Bielsko Biala; Komisji Bioetycznej przy \u015al\u0105skiej Izbie Lekarskiej; Silesian Medical Society (\u015al\u0105ska Izba Lekarska); Bioethics Committee at Lower Silesian Medical Association; Bioethics Committee at the Medical University of Biaystok; Portugal: North Health Regional Administration (ARS Norte); Matosinhos Local Health Unit (ULS Matosinhos); Guimar\u00e3es Hospital; Center Health Regional Administration (ARS Centro); Regional Health Administration of Lisbon and Tagus Valley (ARS LVT); Spain: Comit\u00e9 de \u00c9tica de la Investigaci\u00f3n (CEI) Islas Baleares; CEI Hospital Universitario de Gran Canaria; The Netherlands: Medisch Ethische Toetsingscommissie (METC) Assen exempted this study. All methods of this study were carried out in accordance with relevant (inter-)national guidelines and regulations, and all subjects gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JK reports grants, personal fees, and non-financial support from AstraZeneca, GSK, and Boehringer Ingelheim; grants and personal fees from Chiesi Pharmaceuticals and TEVA; grants from Mundipharma; personal fees from MSD and COVIS Pharma; and also holds 72.5% of shares in the General Practitioners Research Institute\u00a0and 4% of shares in Lothar MedTec GmbH.SB-A has received grants from TEVA, and personal fees from TEVA, Boehringer Ingelheim, AstraZeneca, GSK, Sanofi and Mylan.JCdS reports or personal fees from AstraZeneca, Bial, Boehringer Ingelheim, GSK, Medinfar, Mundipharma and Sanofi.BC received an honorarium from GSK and Sanofi.JvC, LD, IvdH, YJ, BM, KS, NS, TM, BM, ML were employed by General Practitioners Research Institute (GPRI) at the time of the study. In the past three years (2020\u20132023), GPRI conducted investigator- and sponsor-initiated research funded by non-commercial organizations, academic institutes, and pharmaceutical companies (including AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Mundipharma, Novartis, Teva, Valneva, Eli Lilly and G3P).RD has received grants and personal fees from TEVA, Boehringer Ingelheim, AstraZeneca, GSK, Chiesi, Focus Care, and Glenmark.RG has received personal fees from AstraZeneca, GSK, and Chiesi.MGP receives grants from AstraZeneca, GSK and Boehringer Ingelheim.AG is an employee of Boehringer Ingelheim.FL received grants and personal fees from GSK, personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Menarini International, Novartis, Orion, and Trudell International, outside the submitted work.TM has no competing interests to declare.JM received grants from Boehringer Ingelheim, during the conduct of the study; and grants from AstraZeneca, Chiesi, Novartis, and GSK, outside the submitted work.DP reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Mylan, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, Theravance and Zentiva (Sanofi Generics); grants from the British Lung Foundation, Respiratory Effectiveness Group, UK National Health Service, and AKL Research and Development Ltd; personal fees from Cipla, GlaxoSmithKline, Kyorin, Merck, Mundipharma, Airway Vista Secretariat, EPG Communication Holdings Ltd, FIECON Ltd, Fieldwork International, OM Pharma SA, PeerVoice, Phadia AB, Spirosure Inc, Strategic North Limited, Synapse Research Management Partners S.L., Talos Health Solutions, and WebMD Global LLC; non-financial support from Efficacy and Mechanism Evaluation programme and Health Technology Assessment; stock\/stock options from AKL Research and Development Ltd, which produces phytopharmaceuticals; owns 74% of the social enterprise Optimum Patient Care Ltd (Australia and UK) and 92.61% of Observational and Pragmatic Research Institute Pte Ltd (Singapore); and 5% shareholding in Timestamp, which develops adherence monitoring technology.MR-R receives grants and personal fees from AstraZeneca and GSK; and personal fees from Boehringer Ingelheim, Chiesi, Menarini, Mundipharma, Novartis, Pfizer, TEVA and BIAL.IT reports grants and personal fees from GSK, AstraZeneca, Boehringer Ingelheim, Menarini, Novartis, Chiesi and Elpen.OU reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Edmond Pharma, Chiesi and GSK; grants from Edmond Pharma; and personal fees from Napp, Mundipharma, Sandoz, Takeda, Cipla, COVIS, Novartis, Mereobiopharma, Orion, and Menarini.JV has no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}